Selected research
Industry Research
Pharmaceutical Suppositories Industry Research Report 2026
Market perspective
The global Pharmaceutical Suppositories market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Pharmaceutical Suppositories is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Pharmaceutical Suppositories is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Pharmaceutical Suppositories is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Pharmaceutical Suppositories include Bliss Gvs Pharma, Cadila Healthcare, Church And Dwight Uk, Cosette Pharmaceuticals, Glenmark Pharmaceuticals Limited, Intas Pharmaceuticals, Bayer Ag, Pfizer and Novartis International Ag, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Pharmaceutical Suppositories market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pharmaceutical Suppositories Market by Company
Bliss Gvs Pharma
Cadila Healthcare
Church And Dwight Uk
Cosette Pharmaceuticals
Glenmark Pharmaceuticals Limited
Intas Pharmaceuticals
Bayer Ag
Pfizer
Novartis International Ag
Sanofi S.A.
Pharmaceutical Suppositories Segment by Type
Urethral Suppositories
Vaginal Suppositories
Rectal Suppositories
Pharmaceutical Suppositories Segment by Application
Hospital Pharmacies
Online Sales
Retail Pharmacies
Pharmaceutical Suppositories Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Suppositories market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Suppositories and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Suppositories.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Pharmaceutical Suppositories manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Pharmaceutical Suppositories by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Pharmaceutical Suppositories in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Urethral Suppositories
- Vaginal Suppositories
- Rectal Suppositories
Applications
- Hospital Pharmacies
- Online Sales
- Retail Pharmacies
Companies covered
- Bliss Gvs Pharma
- Cadila Healthcare
- Church And Dwight Uk
- Cosette Pharmaceuticals
- Glenmark Pharmaceuticals Limited
- Intas Pharmaceuticals
- Bayer Ag
- Pfizer
- Novartis International Ag
- Sanofi S.A.
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Pharmaceutical Suppositories Market Size (2021-2032)
- 2.2.2 Global Pharmaceutical Suppositories Sales (2021-2032)
- 2.2.3 Global Pharmaceutical Suppositories Market Average Price (2021-2032)
- 2.3 Pharmaceutical Suppositories by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Urethral Suppositories
- 2.3.3 Vaginal Suppositories
- 2.3.4 Rectal Suppositories
- 2.4 Pharmaceutical Suppositories by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital Pharmacies
- 2.4.3 Online Sales
- 2.4.4 Retail Pharmacies
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Pharmaceutical Suppositories Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Pharmaceutical Suppositories Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Pharmaceutical Suppositories Revenue of Manufacturers (2021-2026)
- 3.4 Global Pharmaceutical Suppositories Average Price by Manufacturers (2021-2026)
- 3.5 Global Pharmaceutical Suppositories Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Pharmaceutical Suppositories, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Pharmaceutical Suppositories, Product Type & Application
- 3.8 Global Manufacturers of Pharmaceutical Suppositories, Established Date
- 3.9 Global Pharmaceutical Suppositories Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Bliss Gvs Pharma
- 4.1.1 Bliss Gvs Pharma Company Information
- 4.1.2 Bliss Gvs Pharma Business Overview
- 4.1.3 Bliss Gvs Pharma Pharmaceutical Suppositories Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Bliss Gvs Pharma Pharmaceutical Suppositories Product Portfolio
- 4.1.5 Bliss Gvs Pharma Recent Developments
- 4.2 Cadila Healthcare
- 4.2.1 Cadila Healthcare Company Information
- 4.2.2 Cadila Healthcare Business Overview
- 4.2.3 Cadila Healthcare Pharmaceutical Suppositories Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Cadila Healthcare Pharmaceutical Suppositories Product Portfolio
- 4.2.5 Cadila Healthcare Recent Developments
- 4.3 Church And Dwight Uk
- 4.3.1 Church And Dwight Uk Company Information
- 4.3.2 Church And Dwight Uk Business Overview
- 4.3.3 Church And Dwight Uk Pharmaceutical Suppositories Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Church And Dwight Uk Pharmaceutical Suppositories Product Portfolio
- 4.3.5 Church And Dwight Uk Recent Developments
- 4.4 Cosette Pharmaceuticals
- 4.4.1 Cosette Pharmaceuticals Company Information
- 4.4.2 Cosette Pharmaceuticals Business Overview
- 4.4.3 Cosette Pharmaceuticals Pharmaceutical Suppositories Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Cosette Pharmaceuticals Pharmaceutical Suppositories Product Portfolio
- 4.4.5 Cosette Pharmaceuticals Recent Developments
- 4.5 Glenmark Pharmaceuticals Limited
- 4.5.1 Glenmark Pharmaceuticals Limited Company Information
- 4.5.2 Glenmark Pharmaceuticals Limited Business Overview
- 4.5.3 Glenmark Pharmaceuticals Limited Pharmaceutical Suppositories Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Glenmark Pharmaceuticals Limited Pharmaceutical Suppositories Product Portfolio
- 4.5.5 Glenmark Pharmaceuticals Limited Recent Developments
- 4.6 Intas Pharmaceuticals
- 4.6.1 Intas Pharmaceuticals Company Information
- 4.6.2 Intas Pharmaceuticals Business Overview
- 4.6.3 Intas Pharmaceuticals Pharmaceutical Suppositories Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Intas Pharmaceuticals Pharmaceutical Suppositories Product Portfolio
- 4.6.5 Intas Pharmaceuticals Recent Developments
- 4.7 Bayer Ag
- 4.7.1 Bayer Ag Company Information
- 4.7.2 Bayer Ag Business Overview
- 4.7.3 Bayer Ag Pharmaceutical Suppositories Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Bayer Ag Pharmaceutical Suppositories Product Portfolio
- 4.7.5 Bayer Ag Recent Developments
- 4.8 Pfizer
- 4.8.1 Pfizer Company Information
- 4.8.2 Pfizer Business Overview
- 4.8.3 Pfizer Pharmaceutical Suppositories Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Pfizer Pharmaceutical Suppositories Product Portfolio
- 4.8.5 Pfizer Recent Developments
- 4.9 Novartis International Ag
- 4.9.1 Novartis International Ag Company Information
- 4.9.2 Novartis International Ag Business Overview
- 4.9.3 Novartis International Ag Pharmaceutical Suppositories Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Novartis International Ag Pharmaceutical Suppositories Product Portfolio
- 4.9.5 Novartis International Ag Recent Developments
- 4.10 Sanofi S.A.
- 4.10.1 Sanofi S.A. Company Information
- 4.10.2 Sanofi S.A. Business Overview
- 4.10.3 Sanofi S.A. Pharmaceutical Suppositories Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Sanofi S.A. Pharmaceutical Suppositories Product Portfolio
- 4.10.5 Sanofi S.A. Recent Developments
5 Global Pharmaceutical Suppositories Market Scenario by Region
- 5.1 Global Pharmaceutical Suppositories Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Pharmaceutical Suppositories Sales by Region: 2021-2032
- 5.2.1 Global Pharmaceutical Suppositories Sales by Region: 2021-2026
- 5.2.2 Global Pharmaceutical Suppositories Sales by Region: 2027-2032
- 5.3 Global Pharmaceutical Suppositories Revenue by Region: 2021-2032
- 5.3.1 Global Pharmaceutical Suppositories Revenue by Region: 2021-2026
- 5.3.2 Global Pharmaceutical Suppositories Revenue by Region: 2027-2032
- 5.4 North America Pharmaceutical Suppositories Market Facts & Figures by Country
- 5.4.1 North America Pharmaceutical Suppositories Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Pharmaceutical Suppositories Sales by Country (2021-2032)
- 5.4.3 North America Pharmaceutical Suppositories Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Pharmaceutical Suppositories Market Facts & Figures by Country
- 5.5.1 Europe Pharmaceutical Suppositories Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Pharmaceutical Suppositories Sales by Country (2021-2032)
- 5.5.3 Europe Pharmaceutical Suppositories Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Pharmaceutical Suppositories Market Facts & Figures by Country
- 5.6.1 Asia Pacific Pharmaceutical Suppositories Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Pharmaceutical Suppositories Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Pharmaceutical Suppositories Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Pharmaceutical Suppositories Market Facts & Figures by Country
- 5.7.1 South America Pharmaceutical Suppositories Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Pharmaceutical Suppositories Sales by Country (2021-2032)
- 5.7.3 South America Pharmaceutical Suppositories Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Pharmaceutical Suppositories Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Pharmaceutical Suppositories Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Pharmaceutical Suppositories Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Pharmaceutical Suppositories Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Pharmaceutical Suppositories Sales by Type (2021-2032)
- 6.1.1 Global Pharmaceutical Suppositories Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Pharmaceutical Suppositories Sales Market Share by Type (2021-2032)
- 6.2 Global Pharmaceutical Suppositories Revenue by Type (2021-2032)
- 6.2.1 Global Pharmaceutical Suppositories Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Pharmaceutical Suppositories Revenue Market Share by Type (2021-2032)
- 6.3 Global Pharmaceutical Suppositories Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Pharmaceutical Suppositories Sales by Application (2021-2032)
- 7.1.1 Global Pharmaceutical Suppositories Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Pharmaceutical Suppositories Sales Market Share by Application (2021-2032)
- 7.2 Global Pharmaceutical Suppositories Revenue by Application (2021-2032)
- 7.2.1 Global Pharmaceutical Suppositories Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Pharmaceutical Suppositories Revenue Market Share by Application (2021-2032)
- 7.3 Global Pharmaceutical Suppositories Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Pharmaceutical Suppositories Value Chain Analysis
- 8.1.1 Pharmaceutical Suppositories Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Pharmaceutical Suppositories Production Mode & Process
- 8.2 Pharmaceutical Suppositories Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Pharmaceutical Suppositories Distributors
- 8.2.3 Pharmaceutical Suppositories Customers
9 Global Pharmaceutical Suppositories Analyzing Market Dynamics
- 9.1 Pharmaceutical Suppositories Industry Trends
- 9.2 Pharmaceutical Suppositories Industry Drivers
- 9.3 Pharmaceutical Suppositories Industry Opportunities and Challenges
- 9.4 Pharmaceutical Suppositories Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst